<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Document</title>
  </head>
  <link
    href="https://fonts.googleapis.com/css2?family=Montserrat&display=swap"
    rel="stylesheet"
  />

  <link rel="stylesheet" href="style.css" />
  <body>
    <ul class="header-bar">
      <li><span>CORRESPONDENCE</span></li>
      <li>|</li>
      <li>NOV 13, 2024</li>
      <li>|</li>
      <li class="free">FREE</li>
    </ul>
    <ul>
      <li>
        <h1 class="title">
          Activity of Research-Grade <br />
          Pemivibart against SARS-CoV-2 <br />
          Sublineages
        </h1>
      </li>
      <li><img class="chart" src="chart.png" alt="" /></li>
    </ul>
    <p class="author">Q. Wang and Others</p>

    <br />
    <p>
      SARS-CoV-2 continues to evolve under immunologic pressure. A <br />
      synthesized version of pemivibart, an anti-SARS-CoV-2 monoclonal <br />
      antibody with recent emergency-use authorization, showed mixed <br />
      activity against emerging variants.
    </p>

    <p class="correction">
      <strong>Correction</strong> Pemivibart Activity against Recent SARS-CoV-2
      JN.1 <br />
      Sublineages
    </p>
  </body>
</html>
